(2E)-N-(3,5-Dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enamide

Catalog No.: 
ACZWGQ169
CAS No.: 
329778-44-1
Molecular Formula: 
C18H17Cl2NO4
Molecular Weight: 
382.24
(2E)-N-(3,5-Dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$91.00InquiryInquiry
1g90%$285.00InquiryInquiry
5g90%$1397.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E)-N-(3,5-Dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enamide
IUPAC Name(E)-N-(3,5-dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)acrylamide
MDL No.MFCD01784480
Molecular FormulaC18H17Cl2NO4
Molecular Weight382.24
SMILESO=C(NC1=CC(Cl)=CC(Cl)=C1)/C=C/C2=CC(OC)=C(OC)C(OC)=C2
InChI KeyULCYQBBCCPCIOH-SNAWJCMRSA-N
Synonym(E)-N-(3,5-dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-enamide;N-(3,5-DICHLORO-PHENYL)-3-(3,4,5-TRIMETHOXY-PHENYL)-ACRYLAMIDE
CAS No.329778-44-1

Synthetic Route by SureRoute

1. ACZWGQ169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJWHO509 route compound structure diagram
    ACJWHO50920329-98-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZWGQ169 route product structure diagram
    ACZWGQ169329778-44-1
Inquiry

2. ACZWGQ169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRPGH289 route compound structure diagram
    ACRPGH28990-50-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZWGQ169 route product structure diagram
    ACZWGQ169329778-44-1
Inquiry

3. ACZWGQ169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZWGQ169 route product structure diagram
    ACZWGQ169329778-44-1
Inquiry

Comments (0)